However, mice overexpressing human S100A12 in lung SMC have reduced peribronchial and perivascular inflammation, mucus production, and eosinophilia following acute antigen challenge in asthma, indicating a protective effect [50]. The gene discussed is S100A12; the disease is Increased total eosinophil count.